Skip to main content

and
Your search also matched 8 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you.
results, e.g.

Prognostic significance of general immune competence in acute leukemia

Include preview-only content
  1. Article

    Open Access

    Regulatory networks in mechanotransduction reveal key genes in promoting cancer cell stemness and proliferation

    Tumor-repopulating cells (TRCs) are cancer stem cell (CSC)-like cells with highly tumorigenic and self-renewing abilities, which were selected from tumor cells in soft three-dimensional (3D) fibrin gels with u...

    Wei Huang, Hui Hu, Qiong Zhang, **an Wu, Fuxiang Wei, Fang Yang, Lu Gan in Oncogene (2019)

  2. Article

    Open Access

    A 16q22.1 variant confers susceptibility to colorectal cancer as a distal regulator of ZFP90

    Genome-wide association studies (GWASs) implicate 16q22.1 locus in risk for colorectal cancer (CRC). However, the underlying oncogenic mechanisms remain unknown. Here, through comprehensive filtration, we prio...

    Chen-Yang Yu, Ji-Xuan Han, Junfang Zhang, Penglei Jiang, Chaoqin Shen in Oncogene (2020)

  3. Article

    Open Access

    Nuclear DLC1 exerts oncogenic function through association with FOXK1 for cooperative activation of MMP9 expression in melanoma

    A Rho GTPase-activating protein (RhoGAP), deleted in liver cancer 1 (DLC1), is known to function as a tumor suppressor in various cancer types; however, whether DLC1 is a tumor-suppressor gene or an oncogene in m...

    **ntao Yang, Feng Hu, Jessica Aijia Liu, Shan Yu, May Pui Lai Cheung in Oncogene (2020)

  4. Article

    Open Access

    YAP1 overexpression contributes to the development of enzalutamide resistance by induction of cancer stemness and lipid metabolism in prostate cancer

    Metastatic castration-resistant prostate cancer (mCRPC) is a malignant and lethal disease caused by relapse after androgen-deprivation (ADT) therapy. Since enzalutamide is innovated and approved by US FDA as a...

    Hsiu-Chi Lee, Chien-Hui Ou, Yun-Chen Huang, Pei-Chi Hou, Chad J. Creighton in Oncogene (2021)

  5. Article

    Open Access

    MRE11 promotes oral cancer progression through RUNX2/CXCR4/AKT/FOXA2 signaling in a nuclease-independent manner

    MRE11, the nuclease component of RAD50/MRE11/NBS1 DNA repair complex which is essential for repair of DNA double-strand-breaks in normal cells, has recently garnered attention as a critical factor in solid tum...

    Yen-Yun Wang, Yuk-Kwan Chen, Steven Lo, Tsung-Chen Chi, Yi-Hua Chen in Oncogene (2021)

  6. Article

    Open Access

    Interleukin-37 promotes colitis-associated carcinogenesis via SIGIRR-mediated cytotoxic T cells dysfunction

    Interleukin-37b (hereafter called IL-37) was identified as fundamental inhibitor of natural and acquired immunity. The molecular mechanism and function of IL-37 in colorectal cancer (CRC) has been elusive. Her...

    Zhen Wang, Fan-lian Zeng, Ya-wen Hu in Signal Transduction and Targeted Therapy (2022)

  7. Article

    Open Access

    S1PR1 regulates ovarian cancer cell senescence through the PDK1-LATS1/2-YAP pathway

    Cell senescence deters the activation of various oncogenes. Induction of senescence is, therefore, a potentially effective strategy to interfere with vital processes in tumor cells. Sphingosine-1-phosphate rec...

    Yi-** Tao, Heng-Yan Zhu, Qian-Yuan Shi, Cai-**a Wang, Yu-**n Hua, Han-Yin Hu in Oncogene (2023)